Kernel Flow

Cybin Inc. (NYSE:CYBN) and Kernel, two companies that undertook a joint feasibility study to evaluate the effects ketamine has on blood flow in the brain in late March, announced their results. In a video shared by Kernel, the company’s CEO and founder, Bryan...